Female Infertility Diagnosis Market, By Diagnostic Type (Ovarian Reserve Testing, Ovulation Testing, Laparoscopy, Hormone Testing, Imaging Techniques, Genetic Screening and Others), By Condition, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
ANV6324
|
Published Date
November 2026
|
Pages
355
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Female Infertility Diagnosis market size was valued at US$ 5,690.1 Million in 2025, expanding at a CAGR of 8.8% from 2026 to 2033.
A female infertility diagnosis is the testing process conducted to determine the reason behind why the woman could have problems either conceiving or completing the full term pregnancy. Medical history will be obtained together with physical examination, and then tests like ovulation testing, blood tests for hormones and ovarian reserve (AMH, FSH, LH), pelvic ultrasound scanning, and hysterosalpingography to check if the fallopian tubes are open and hysteroscopy, which checks the lining of the uterus, will be done. In some cases, genetic testing is done. This helps in detecting problems like ovulatory disorders, PCOS, endometriosis, tube obstruction, fibroids, or depleted egg reserves. It helps doctors to make decisions on what the best treatment options are, which could be drug therapy or fertility treatment. Simple home hormone tests are making it easier for women to learn about their cycle before visiting the clinics. These diagnostic tests assist in the early detection of fertility-related issues and allow doctors to choose the best treatment options.
Female Infertility Diagnosis Market- Market Dynamics
Rising Infertility Burden And Delayed Childbearing To Boost Market Demand
The rising infertility burden and increasing trend of delayed childbearing act as significant factors driving the female infertility diagnosis market, along with increasing awareness regarding early diagnosis of infertility, which will increase the need for diagnostic tests and procedures for identification of causes for infertility and proper treatment. In July 2026, according to the Integrated Health & Wellbeing (Org) Council’s White Paper, the prevalence of infertility is 10-15% in married couples in India, accounting for 27.5 million couples.
As per the document, the prevalence rate of primary infertility is 18.7 per 1000 women (1.9%), and the prevalence of secondary infertility has gone up from 27% to 28%. Late parenthood is another cause for infertility. The age at marriage is delayed, women\'s educational levels have risen, and there are many dual-career couples. It means that there may be issues with the quality of eggs because of the above reasons. The total fertility rate in India is 2.0 children per woman, which is less than the replacement rate of 2.1. This will lead to an increase in demand for diagnosing infertility in India.
Female Infertility Diagnosis Market- Segmentation Analysis:
The Global Female Infertility Diagnosis market is segmented on the basis of Diagnostic Type, Condition, End User, and Region.
Under the diagnosis type, ovulation testing holds a prominent position in the market. Confirming whether and when a woman ovulates is usually the first step in any fertility work-up, and ovulation tests are simple, affordable, and available both in clinics and at home, which gives this segment a very wide user base. In June 2025, the Journal of Medical Internet Research (Org) stated that pregnancy and ovulation testing accounted for 3,446 messages (12.8%) among 26,919 infertility-related social media messages analyzed in France. The study also found that 5,068 messages (18.9%) focused on ovulation cycle tracking, highlighting growing discussions around monitoring ovulation and identifying fertile periods. These findings indicate increasing attention to ovulation monitoring and testing among individuals experiencing infertility.
In terms of condition, PCOS (Polycystic Ovary Syndrome) holds a key position in the Female Infertility Diagnosis market because it causes a lot of ovulation and hormone-related issues. Early diagnosis helps in identifying any complications that come with infertility and provide effective treatment. In June 2026, Aspire Fertility provided an update on Polycystic Ovary Syndrome (PCOS). They revealed the new name for PCOS, which is Polyendocrine Metabolic Ovarian Syndrome (PMOS), and the implications of this for women. There has been greater awareness of this problem, leading to a rise in demand for diagnosis.
Female Infertility Diagnosis Market- Geographical Insights
North America maintains a prominent position in the global Female Infertility Diagnosis market due to increased awareness about reproductive health, the existence of fertility centers, high expenditure on women\'s healthcare and reimbursement policies, and the presence of well-established diagnostic companies and digital health care start-up companies. In May 2026, as per the U.S. Department of Health & Human Services\' Office on Women\'s Health, the National Women\'s Health Week (NWHW) emphasized 4 main areas of focus, which are aimed at raising awareness about women\'s health in America.
These areas of focus are prevention and early detection throughout life, sex differences and hormones, chronic disease and healthy aging, and innovation in women\'s health. This would help to encourage preventative screenings, education about reproductive health, knowledge about hormones, and interventions to make informed choices about healthcare among women. It would also help to make evidence-based health information more accessible to people. Such initiatives would prove helpful in the growth of the market in this region through increased awareness about reproductive health and female infertility diagnosis.
Female Infertility Diagnosis Market- Competitive Landscape:
The Female Infertility Diagnosis market is competitive and evolving, with large diagnostics groups, consumer health brands, and fast-growing at-home testing companies all competing for positions. Some of the key players include Church & Dwight Co., Inc., Revvity, Inc., Siemens Healthineer, and Swiss Precision Diagnostics, who offer hormone assays, ovulation tests, laboratory platforms, and women\'s health devices. In January 2025, Siemens Healthineers unveiled its comprehensive portfolio of advanced imaging at AOCR 2025, which includes such systems as ACUSON Maple and ACUSON Sequoia with AI-based imaging capabilities and used for diagnostic examinations to contribute to the development of advanced imaging technology in medicine.
Recent Developments:
- In May 2026, Revvity received FDA clearance for its Total Testosterone automated chemiluminescence immunoassay (ChLIA) from its subsidiary Immunodiagnostic Systems (IDS). This assay expanded the company\'s hormone-testing portfolio by allowing to measure total testosterone together with free testosterone and sex hormone-binding globulin (SHBG) on a single platform.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL FEMALE INFERTILITY DIAGNOSIS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- bioMérieux SA
- Hoffmann-La Roche Ltd.
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- Sysmex Corporation
- Danaher Corporation (Beckman Coulter)
- Revvity, Inc.
- CooperSurgical Inc.
- Merck KGaA
- Randox Laboratories Ltd.
- QuidelOrtho Corporation
- FUJIFILM Wako Pure Chemical Corporation
- Tosoh Bioscience, Inc.
- Biomerica, Inc.
- Mindray Medical International Limited
- Others
GLOBAL FEMALE INFERTILITY DIAGNOSIS MARKET, BY DIAGNOSTIC TYPE- MARKET ANALYSIS, 2020 - 2033
- Ovarian Reserve Testing
- Ovulation Testing
- Laparoscopy
- Hormone Testing
- Imaging Techniques
- Genetic Screening
- Others
GLOBAL FEMALE INFERTILITY DIAGNOSIS MARKET, BY CONDITION- MARKET ANALYSIS, 2020 - 2033
- Tubal Factor Infertility
- PCOS
- Uterine Abnormalities
- Endometriosis
- Unexplained Infertility
- Age-related Infertility
GLOBAL FEMALE INFERTILITY DIAGNOSIS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Diagnostic Laboratories
- Hospitals
- At-Home Testing Providers
- Fertility Clinics
- Others
GLOBAL FEMALE INFERTILITY DIAGNOSIS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
TABLE OF CONTENT
1. Female Infertility Diagnosis Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Female Infertility Diagnosis Market Snippet by Diagnostic Type
2.1.2. Female Infertility Diagnosis Market Snippet by Condition
2.1.3. Female Infertility Diagnosis Market Snippet by End User
2.1.4. Female Infertility Diagnosis Market Snippet by Country
2.1.5. Female Infertility Diagnosis Market Snippet by Region
2.2. Competitive Insights
3. Female Infertility Diagnosis Key Market Trends
3.1. Female Infertility Diagnosis Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Female Infertility Diagnosis Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Female Infertility Diagnosis Market Opportunities
3.4. Female Infertility Diagnosis Market Future Trends
4. Female Infertility Diagnosis Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Female Infertility Diagnosis Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Female Infertility Diagnosis Market Landscape
6.1. Female Infertility Diagnosis Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Female Infertility Diagnosis Market – By Diagnostic Type
7.1. Overview
7.1.1. Segment Share Analysis, By Diagnostic Type, 2025 & 2033 (%)
7.1.2. Ovarian Reserve Testing
7.1.3. Ovulation Testing
7.1.4. Laparoscopy
7.1.5. Hormone Testing
7.1.6. Imaging Techniques
7.1.7. Genetic Screening
7.1.8. Others
8. Female Infertility Diagnosis Market – By Condition
8.1. Overview
8.1.1. Segment Share Analysis, By Condition, 2025 & 2033 (%)
8.1.2. Tubal Factor Infertility
8.1.3. PCOS
8.1.4. Uterine Abnormalities
8.1.5. Endometriosis
8.1.6. Unexplained Infertility
8.1.7. Age-related Infertility
9. Female Infertility Diagnosis Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
9.1.2. Diagnostic Laboratories
9.1.3. Hospitals
9.1.4. At-Home Testing Providers
9.1.5. Fertility Clinics
9.1.6. Others
10. Female Infertility Diagnosis Market – By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
10.2. North America
10.2.1. Overview
10.2.2. Female Infertility Diagnosis Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.2.4. North America Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.2.5. North America Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Female Infertility Diagnosis Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.16. Denmark
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.16.3. Denmark Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.3.16.4. Denmark Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.3.16.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.17. Rest of Europe
10.3.17.1. Overview
10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.17.3. Rest of the Europe Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.3.17.4. Rest of the Europe Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Female Infertility Diagnosis Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.15. Taiwan
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.15.3. Taiwan Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.4.15.4. Taiwan Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.4.15.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.16. Vietnam
10.4.16.1. Overview
10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.16.3. Vietnam Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.4.16.4. Vietnam Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.4.16.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.17. Rest of APAC
10.4.17.1. Overview
10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.17.3. Rest of APAC Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.4.17.4. Rest of APAC Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Female Infertility Diagnosis Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Female Infertility Diagnosis Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.13. Iran
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.13.3. Iran Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.6.13.4. Iran Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.6.13.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.14. Qatar
10.6.14.1. Overview
10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.14.3. Qatar Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.6.14.4. Qatar Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.6.14.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.15. Rest of MEA
10.6.15.1. Overview
10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.15.3. Rest of MEA Market Size and Forecast, By Diagnostic Type, 2020 - 2033 (US$ Million)
10.6.15.4. Rest of MEA Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
10.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11. Key Vendor Analysis- Female Infertility Diagnosis Industry
11.1. Competitive Benchmarking
11.1.1. Competitive Dashboard
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Abbott Laboratories
11.2.2. bioMérieux SA
11.2.3. F. Hoffmann-La Roche Ltd.
11.2.4. Siemens Healthineers AG
11.2.5. Thermo Fisher Scientific Inc.
11.2.6. Sysmex Corporation
11.2.7. Danaher Corporation (Beckman Coulter)
11.2.8. Revvity, Inc.
11.2.9. CooperSurgical Inc.
11.2.10. Merck KGaA
11.2.11. Randox Laboratories Ltd.
11.2.12. QuidelOrtho Corporation
11.2.13. FUJIFILM Wako Pure Chemical Corporation
11.2.14. Tosoh Bioscience, Inc.
11.2.15. Biomerica, Inc.
11.2.16. Mindray Medical International Limited
11.2.17. Others
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL FEMALE INFERTILITY DIAGNOSIS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- bioMérieux SA
- Hoffmann-La Roche Ltd.
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- Sysmex Corporation
- Danaher Corporation (Beckman Coulter)
- Revvity, Inc.
- CooperSurgical Inc.
- Merck KGaA
- Randox Laboratories Ltd.
- QuidelOrtho Corporation
- FUJIFILM Wako Pure Chemical Corporation
- Tosoh Bioscience, Inc.
- Biomerica, Inc.
- Mindray Medical International Limited
- Others
GLOBAL FEMALE INFERTILITY DIAGNOSIS MARKET, BY DIAGNOSTIC TYPE- MARKET ANALYSIS, 2020 - 2033
- Ovarian Reserve Testing
- Ovulation Testing
- Laparoscopy
- Hormone Testing
- Imaging Techniques
- Genetic Screening
- Others
GLOBAL FEMALE INFERTILITY DIAGNOSIS MARKET, BY CONDITION- MARKET ANALYSIS, 2020 - 2033
- Tubal Factor Infertility
- PCOS
- Uterine Abnormalities
- Endometriosis
- Unexplained Infertility
- Age-related Infertility
GLOBAL FEMALE INFERTILITY DIAGNOSIS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Diagnostic Laboratories
- Hospitals
- At-Home Testing Providers
- Fertility Clinics
- Others
GLOBAL FEMALE INFERTILITY DIAGNOSIS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Analystview Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
